Skip to content

Lifecore Biomedical, Inc. LFCR Reportable Segment — Depreciation

Similar metrics at other companies

TaskUs logo
TASKReportable Segment — Depreciation
$11.03M+10.3%
N-able logo
NABLReportable Segment — Depreciation
$4.8M+14.3%
Citizens Community Bancorp logo
CZWIReportable Segment — Depreciation
$474K-9.9%
Latham Group, Inc. logo
SWIMSingle Reportable Segment — Depreciation
$5.68M+13.7%
Claritev Corporation logo
CTEVReportable Segment — Depreciation
$25.18M+2.6%
Concentrix Corporation logo
CNXCReportable Segment — Depreciation
$58.06M+3.4%

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-37.3%
Enterprise value$333.06M+6.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s reportable segment — depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s reportable segment — depreciation?
Lifecore Biomedical, Inc. (LFCR) reported reportable segment — depreciation of $2.31M in Q1 2026.
What does reportable segment — depreciation mean?
This metric represents the systematic allocation of the cost of tangible assets used by the segment over their useful lives. It provides insight into the capital intensity of the segment's manufacturing infrastructure and the ongoing investment required to maintain production capabilities.